EUVIMEDEUVIMED entdecken
Open Access

Deep Learning Model for Natural Language to Assess Effectiveness of Patients With Non–Muscle Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin Therapy

Makito Miyake iD, Naohiro Yonemoto iD, Kanae Togo iD, Linghua Xu iD, Tomoyo Oguri iD, Masayuki Tanaka iD, Yoshiyuki Hasegawa iD, Yoshinobu Izawa, Kenji Araki

JCO Clinical Cancer Informatics · 2025

DOI: 10.1200/cci-24-00249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025. Verfasst von Makito Miyake und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, BCG Vaccine, Deep Learning, Natural Language Processing. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Collecting information on clinical outcomes (recurrence/progression) from complex treatment courses in non–muscle invasive bladder cancer (NMIBC) is challenging and time-consuming. We developed a deep learning natural language processing model to assess outcomes in patients with NMIBC using vast data from electronic health records (EHRs). METHODS This retrospective study analyzed data from Japanese adults with NMIBC who started Bacillus Calmette-Guérin (BCG) induction therapy between April 2016 and June 2022. A Bidirectional Encoder Representations from Transformers (BERT) model was trained to classify outcomes, supported by human review for past history records. The model's performance was assessed by precision, recall, and F1 scores. We compared the effectiveness of BCG therapy between completion (patients who completed therapy) and non-completion groups. RESULTS Of 372 patients studied, 79.3% and 20.7% were in the completion group and the non-completion group, respectively. The final BERT model achieved average F1 scores of 0.91 and 0.98 for time to recurrence (TTR), and 0.74 and 0.94 for time to progression (TTP) before and after human support, respectively. The hazard ratio for TTR in BCG completion versus non-completion groups was 0.40 (95% CI, 0.26 to 0.62) by a multivariate Cox proportional hazard model and 0.41 (95% CI, 0.26 to 0.63) by inverse probability of treatment weighting. CONCLUSION The developed model could compare the clinical outcomes between treatments in patients with NMIBC using EHRs. Human support, although required, was needed in only 10% documents and was deemed feasible. The model was able to demonstrate the difference in TTR and TTP between BCG completion and non-completion groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsBCG VaccineDeep LearningNatural Language ProcessingHumansMaleFemaleRetrospective StudiesAgedMiddle AgedAdministration, IntravesicalElectronic Health RecordsTreatment OutcomeAged, 80 and overNeoplasm Recurrence, LocalAdjuvants, ImmunologicNon-Muscle Invasive Bladder Neoplasms

Substanzen

BCG VaccineAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Biostatistics, Faculty of Medicine, University of Toyama. Toyama-shi, Toyama, Japan.
  • Access & Value, Pfizer Japan Inc, Shibuya-ku, Tokyo, Japan.
  • Oncology Medical Affairs, Pfizer Japan Inc, Shibuya-ku, Tokyo, Japan.
  • System Integration Sector, NTT DATA Corporation, Koto-ku, Tokyo, Japan.
  • Faculty of Medicine, University of Miyazaki Hospital, Miyazaki-shi, Miyazaki, Japan.

ORCID-Profile: Makito Miyake, Naohiro Yonemoto, Kanae Togo, Linghua Xu, Tomoyo Oguri, Masayuki Tanaka, Yoshiyuki Hasegawa

Zitieren

APA

Miyake, M., Yonemoto, N., Togo, K., Xu, L., Oguri, T., Tanaka, M., Hasegawa, Y., Izawa, Y., & Araki, K. (2025). Deep Learning Model for Natural Language to Assess Effectiveness of Patients With Non–Muscle Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin Therapy. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00249

Vancouver

Miyake M, Yonemoto N, Togo K, Xu L, Oguri T, Tanaka M, et al. Deep Learning Model for Natural Language to Assess Effectiveness of Patients With Non–Muscle Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin Therapy. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-24-00249

BibTeX
@article{Miyake2025,
  author = {Miyake, Makito and Yonemoto, Naohiro and Togo, Kanae and Xu, Linghua and Oguri, Tomoyo and Tanaka, Masayuki and Hasegawa, Yoshiyuki and Izawa, Yoshinobu and Araki, Kenji},
  title = {Deep Learning Model for Natural Language to Assess Effectiveness of Patients With Non–Muscle Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin Therapy},
  journal = {JCO Clinical Cancer Informatics},
  year = {2025},
  doi = {10.1200/cci-24-00249}
}
Kostenlos starten →